Nobuhisa Ishikawa - Department of Respiratory Medicine, Hiroshima Prefectural Hospital

基本信息

浏览量：150

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 207 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Retrospective Analysis of the Efficacy of Oral Dexamethasone in Combination with Docetaxel Plus Ramucirumab Therapy for Previously Treated Lung Cancer

Kosuke Hamai, Ryo Katsura,Shinya Miyake,Suguru Fujita,Shinpei Tada,Tetsu Hirakawa,Sayaka Ueno,Takuya Tanimoto,Nobuhisa Ishikawa

CANCER CONTROL (2024)

引用0浏览0WOS引用

Comparison of Efficacy of Gefitinib and Osimertinib for Untreated EGFR Mutation-Positive Non-Small-cell Lung Cancer in Patients with Poor Performance Status

Kazuhisa Nakashima,Hiroaki Kodama,Haruyasu Murakami,Toshiaki Takahashi,Keita Kawakado,Takashi Yanagawa, Kashu Kitani, Takamasa Hottta, Masaaki Abe,Kosuke Hamai,Takuya Tanimoto,Nobuhisa Ishikawa,Tomoki Tamura,Shoichi Kuyama,Takeshi Isobe,Yukari Tsubata

Respiratory investigation（2024）

引用0浏览0WOS引用

D-dimer Cut-off Value for Predicting Venous Thromboembolism at the Initial Diagnosis in Japanese Patients with Advanced Lung Cancer

Keita Kawakado,Yukari Tsubata,Takamasa Hotta,Masahiro Yamasaki,Nobuhisa Ishikawa,Takeshi Masuda,Tetsuya Kubota,Kunihiko Kobayashi,Takeshi Isobe

JAPANESE JOURNAL OF CLINICAL ONCOLOGYno. 9 (2024): 1032-1036

引用0浏览0WOS引用

Risk Factors for Bleeding Events in Japanese Patients with Advanced Lung Cancer: Data from the Rising-VTE/NEJ037 Study

Keita Kawakado,Yukari Tsubata,Takamasa Hotta,Masahiro Yamasaki,Nobuhisa Ishikawa,Kazunori Fujitaka,Tetsuya Kubota,Kunihiko Kobayashi,Takeshi Isobe

Cancersno. 2 (2024): 301-301

引用0浏览0WOS引用

Safety and Efficacy of Durvalumab Plus Carboplatin and Etoposide for Patients with Previously Untreated Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) with a Poor Performance Status: the Results from Phase II Single-Arm Study (NEJ045A Study)

Yu Saida,Tetsuhiko Asao,Satoshi Watanabe,Akira Kisohara,Kazuma Kishi,Ryo Morita, Taku Nagao,Yoko Tsukita,Naoki Furuya,Taichi Miyawaki,Nobuhisa Ishikawa, Tadaaki Yamada,Takahiro Tanaka,Satoshi Morita, Toshiaki Kikuchi, Makoto Maemondo,Kunihiko Kobayashi

Journal of Clinical Oncology（2024）

引用1浏览0引用

Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) after EGFR-TKI-Induced Interstitial Lung Disease (Cs-Lung-005)

Nobuhiro Kanaji,Eiki Ichihara, Takaaki Tanaka,Takashi Ninomiya,Toshiyuki Kozuki,Nobuhisa Ishikawa,Kazuya Nishii,Hiroyasu Shoda,Kakuhiro Yamaguchi,Keita Kawakado,Yuko Toyoda,Masaaki Inoue,Nobuyuki Miyatake,Naoki Watanabe,Takuya Inoue,Hitoshi Mizoguchi,Yuta Komori, Kazuki Kojima,Norimitsu Kadowaki

LUNGno. 1 (2024): 63-72

引用0浏览0引用

A Phase II Study of Daily Carboplatin Plus Irradiation Followed by Durvalumab Therapy for Older Adults (≥75 Years) with Unresectable III Non-Small-cell Lung Cancer and Performance Status of 2: NEJ039A

A. Mouri,A. Kisohara,R. Morita,R. Ko, T. Nakagawa,T. Makiguchi, K. Isobe,N. Ishikawa, T. Kondo,M. Akiyama,A. Bessho,R. Honda,K. Yoshimura,H. Kagamu, S. Kato,K. Kobayashi,K. Kaira,M. Maemondo

ESMO OPENno. 10 (2024)

引用0浏览0WOS引用

Burden of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Virus Infections in Japanese Adults in the Hospitalized Acute Respiratory Tract Infection Study

Masaharu Shinkai,Shinichiro Ota,Nobuhisa Ishikawa,Takuya Tanimoto,Hiroki Suzuki,Shuichi Abe,Yannick Vandendijck,Yoshikazu Nakayama,Yoko Murata

RESPIRATORY INVESTIGATIONno. 4 (2024): 717-725

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn